Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancerDavid Miles, Giulia Bianchi, Zhimin Shao et al.|Annals of Oncology|2021Cited by 724
Identification and characterization of alphavirus M1 as a selective oncolytic virus targeting ZAP-defective human cancersYuan Lin, Guangmei Yan, Haipeng Zhang et al.|Proceedings of the National Academy of Sciences|2014Cited by 167
IKKα restoration via EZH2 suppression induces nasopharyngeal carcinoma differentiationMin Yan, Quentin Liu|Nature Communications|2014Cited by 74
CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling PathwayMingde Zang, Min Yan|PLoS ONE|2014Cited by 66
Activation of Cyclic Adenosine Monophosphate Pathway Increases the Sensitivity of Cancer Cells to the Oncolytic Virus M1Kai Li, Guangmei Yan, Haipeng Zhang et al.|Molecular Therapy|2015Cited by 44